ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Ophthalmology

Top Ophthalmology Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NORMAN ZABRISKIE MD

Ophthalmology

5,514

$367K

833
772 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

56%
prescriptions for brand name drugs

Avg: 63%

$67
Average prescription price

Avg: $71

MATTHEW PARSONS MD

Ophthalmology

2,595

$173K

648
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 63%

$67
Average prescription price

Avg: $71

JASON AHEE MD

Ophthalmology

2,451

$143K

581
563 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

60%
prescriptions for brand name drugs

Avg: 63%

$58
Average prescription price

Avg: $71

DAVID BRODSTEIN M.D.

Ophthalmology

2,088

$171K

308
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

72%
prescriptions for brand name drugs

Avg: 63%

$82
Average prescription price

Avg: $71

CHAD ANDERSON M.D.

Ophthalmology

1,929

$158K

505
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

76%
prescriptions for brand name drugs

Avg: 63%

$82
Average prescription price

Avg: $71

JON SILER MD

Ophthalmology

1,899

$126K

319
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

60%
prescriptions for brand name drugs

Avg: 63%

$66
Average prescription price

Avg: $71

ALAN CRANDALL MD

Ophthalmology

1,853

$131K

443
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

67%
prescriptions for brand name drugs

Avg: 63%

$71
Average prescription price

Avg: $71

COREY MILLER MD

Ophthalmology

1,802

$135K

533
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

74%
prescriptions for brand name drugs

Avg: 63%

$75
Average prescription price

Avg: $71

SHARON RICHENS MD

Ophthalmology

1,800

$154K

537
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

76%
prescriptions for brand name drugs

Avg: 63%

$85
Average prescription price

Avg: $71

ROBERT CIONNI M.D.

Ophthalmology

1,735

$160K

503
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

82%
prescriptions for brand name drugs

Avg: 63%

$92
Average prescription price

Avg: $71

JASON GOLDSMITH MD

Ophthalmology

1,722

$105K

226
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

49%
prescriptions for brand name drugs

Avg: 63%

$61
Average prescription price

Avg: $71

JOHN ALDER M.D.

Ophthalmology

1,452

$80.4K

338
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

55%
prescriptions for brand name drugs

Avg: 63%

$55
Average prescription price

Avg: $71

TIMOTHY BYERS MD

Ophthalmology

1,279

$84.9K

304
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

57%
prescriptions for brand name drugs

Avg: 63%

$66
Average prescription price

Avg: $71

JOHN FASSIO MD

Ophthalmology

1,268

$89.1K

273
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

59%
prescriptions for brand name drugs

Avg: 63%

$70
Average prescription price

Avg: $71

MAJID MOSHIRFAR MD

Ophthalmology

1,226

$97.7K

331
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

68%
prescriptions for brand name drugs

Avg: 63%

$80
Average prescription price

Avg: $71

MICHAEL WILCOX MD

Ophthalmology

1,221

$94.2K

336
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

78%
prescriptions for brand name drugs

Avg: 63%

$77
Average prescription price

Avg: $71

MATHEW TEMPEST MD

Ophthalmology

1,119

$85.9K

235
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

72%
prescriptions for brand name drugs

Avg: 63%

$77
Average prescription price

Avg: $71

JAMES THEURER MD

Ophthalmology

1,118

$81.4K

253
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 63%

$73
Average prescription price

Avg: $71

RACHEL BENATOR M.D.

Ophthalmology

1,111

$72.5K

266
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

54%
prescriptions for brand name drugs

Avg: 63%

$65
Average prescription price

Avg: $71

ALBERT UNGRICHT MD

Ophthalmology

1,099

$68.1K

211
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

48%
prescriptions for brand name drugs

Avg: 63%

$62
Average prescription price

Avg: $71

ROBERT WING MD

Ophthalmology

1,083

$87.7K

294
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 63%

$81
Average prescription price

Avg: $71

MARK MIFFLIN MD

Ophthalmology

1,056

$59K

272
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

68%
prescriptions for brand name drugs

Avg: 63%

$56
Average prescription price

Avg: $71

BRYCE BARKER M.D.

Ophthalmology

1,051

$73.1K

229
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

64%
prescriptions for brand name drugs

Avg: 63%

$70
Average prescription price

Avg: $71

SCOTT SYKES M.D.

Ophthalmology

1,050

$86.3K

279
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

77%
prescriptions for brand name drugs

Avg: 63%

$82
Average prescription price

Avg: $71

WALTER JAUSSI MD

Ophthalmology

1,049

$48K

324
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

60%
prescriptions for brand name drugs

Avg: 63%

$46
Average prescription price

Avg: $71

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank